Professor, Department of Public Health, Kaohsiung Medical University
Taiwan’s health care system is the world’s high-quality and internationally recognized health care system, but health executives must look at the overall national health in terms of all disease burdens, not just the medical conditions themselves. The “three levels of disease prevention” is well-known disease control model, and the era of rapid development of medical technology is still insufficient, and the interventional needs of the tertiary level are increasing, and the most important thing is still prevention in the primary level. We select ischemic cardiovascular disease and cerebrovascular disease as the target, invite medical experts in the field of cardiovascular and cerebrovascular diseases and researchers in the field of disease burden and loss of life years to discuss together, try to sort out the risk factors of the two diseases and their related epidemiological conditions, and pay more attention to the discussion of the long-term care system and the disability adjustment life year (DALY) and the quality adjustment life year (QALY), so as to fully present the so-called overall disease burden is the aspect that the stakeholder should consider. It is hoped that the information compiled by this project can be provided with a reference for the future prevention of relevant diseases, and will become a standardized data presented in the annual report. Cardiovascular disease and cerebrovascular disease risk factors are similar, but the clinical treatment effect is very different, the latter to continue the high cost of society is also the main reason for the long time of bed rest in the people at the end of life, the former due to medical progress to produce all (normal work life) or none (short-term death) result, which can be presented by the data of the long-term care system. If the incidence, prevalence rate, mortality rate and average healthy life expectancy of cardiovascular disease and cerebrovascular disease in Taiwan can be further understood from the literature review and data analysis and international comparison and the difference between the risk factors of the two diseases, then we can find the causes and strategy to effectively formulate policies for the prevention and treatment of cardiovascular disease and cerebrovascular disease, which will improve national health indicators and reduce social cost.